Mixed messages A NEW class of drugs hailed by some as the best hope of defeating cancer is experiencing mixed fortunes. The drugs giant Bristol-Myers Squibb has backed out of plans to develop the drug angiostatin. But a related drug, endostatin, is looking promising enough for the US National Cancer Institute to announce that it wants to … News
Monster mash EVERY cause needs a martyr. And in Arpad Pusztai, the scientist at the centre of the row over transgenic potatoes that has engulfed Britain, opponents of GM foods seem finally to have struck gold. Not since King Ludd and his followers marched on the cotton mills of Lancashire has there been such virulent hostility to … Opinion
Total control START with the polyester leisure suit tucked in the back of the wardrobe and make your way around the house. Guaranteed, the place will be full of plastics and artificial fibres. Shampoo bottles, water pipes, hi-fi casing, kitchen worktops, guttering—the 20th century would hardly work without them. But despite their huge variety, most plastics and … Features
A theory of everything ALBERT EINSTEIN once said: "The most incomprehensible thing about the Universe is that it is comprehensible." The Universe is unbelievably large and contains an unthinkable number of things. Yet we can model much of its history, account for its structure, predict its future and understand the behaviour of a bewildering variety of the objects it … Inside Science
Feedback WE CAN never know what Polly the sheep and her sister Molly feel about being famous clones. But it is possible to surmise that one aspect of their situation they don't like much is the tests they have to endure to find out just how alike they are. In the most recent of these, experts … Regulars